1-20 of 30
Blood Advances Talks
Close
Sort by
Journal Articles

GRNDaD: big data and sickle cell disease

Sophie Lanzkron, Deepa Manwani, Payal Desai, Julie Kanter, Jane Little
Journal: Blood Advances
Blood Adv (2022) 6 (3): 1088.
https://doi.org/10.1182/bloodadvances.2021005282
Published: 2022
Includes: Supplemental data
Journal Articles

Investigational curative gene therapy approaches to sickle cell disease

Clinical Trials & Observations
David A. Williams, Erica Esrick
Journal: Blood Advances
Blood Adv (2021) 5 (23): 5452.
https://doi.org/10.1182/bloodadvances.2021005567
Published: 2021
Includes: Supplemental data
Journal Articles

Why is AAV FVIII gene therapy not approved by the US Food and Drug Administration yet?

Clinical Trials & Observations
Valder R. Arruda
Journal: Blood Advances
Blood Adv (2021) 5 (20): 4313.
https://doi.org/10.1182/bloodadvances.2021004760
Published: 2021
Includes: Supplemental data
Journal Articles

Thrombosis and novel hemophilia therapies: the fine line between clotting and bleeding

Maureane Hoffman
Journal: Blood Advances
Blood Adv (2021) 5 (18): 3736.
https://doi.org/10.1182/bloodadvances.2021004802
Published: 2021
Includes: Supplemental data
Journal Articles

Concizumab: a novel anti-TFPI therapeutic for hemophilia

Clinical Trials & Observations
Amy D. Shapiro
Journal: Blood Advances
Blood Adv (2021) 5 (1): 279.
https://doi.org/10.1182/bloodadvances.2019001140
Published: 2021
Includes: Supplemental data
Journal Articles

Naive T-cell depletion in stem cell transplantation

Marie Bleakley
Journal: Blood Advances
Blood Adv (2020) 4 (19): 4980.
https://doi.org/10.1182/bloodadvances.2020001888
Published: 2020
Includes: Supplemental data
Journal Articles

The management of venous thromboembolism in hospitalized patients with COVID-19

Clinical Trials & Observations
Alex C. Spyropoulos
Journal: Blood Advances
Blood Adv (2020) 4 (16): 4028.
https://doi.org/10.1182/bloodadvances.2020002496
Published: 2020
Includes: Supplemental data
Journal Articles

Gene therapy for hemophilia: anticipating the unexpected

Clinical Trials & Observations
Glenn F. Pierce
Journal: Blood Advances
Blood Adv (2020) 4 (15): 3788.
https://doi.org/10.1182/bloodadvances.2020002142
Published: 2020
Includes: Supplemental data
Journal Articles

COVID-19 coagulopathy vs disseminated intravascular coagulation

Marcel Levi
Journal: Blood Advances
Blood Adv (2020) 4 (12): 2850.
https://doi.org/10.1182/bloodadvances.2020002197
Published: 2020
Includes: Supplemental data
Journal Articles

The great platelet paradox: evolution of platelet contribution to hemostasis, inflammation, and thrombosis after injury

Matthew D. Neal
Journal: Blood Advances
Blood Adv (2020) 4 (11): 2556.
https://doi.org/10.1182/bloodadvances.2019001166
Published: 2020
Includes: Supplemental data
Journal Articles

Access to specialized care and outcomes in adults with acute leukemias

Lori Muffly, Vijaya R. Bhatt
Journal: Blood Advances
Blood Adv (2020) 4 (7): 1538.
https://doi.org/10.1182/bloodadvances.2019000660
Published: 2020
Includes: Supplemental data
Journal Articles

The changing landscape of anticoagulation in cancer-associated thrombosis

Clinical Trials & Observations
Agnes Y. Y. Lee
Journal: Blood Advances
Blood Adv (2020) 4 (5): 969.
https://doi.org/10.1182/bloodadvances.2019000842
Published: 2020
Includes: Supplemental data
Journal Articles

TA-TMA: state of the art for diagnosis and treatment

Clinical Trials & Observations
Christopher C. Dvorak
Journal: Blood Advances
Blood Adv (2020) 4 (1): 217.
https://doi.org/10.1182/bloodadvances.2019000321
Published: 2020
Includes: Supplemental data
Journal Articles

Inherited predisposition to myeloid malignancies

Lucy A. Godley
Journal: Blood Advances
Blood Adv (2019) 3 (17): 2688.
https://doi.org/10.1182/bloodadvances.2019000172
Published: 2019
Includes: Supplemental data
Journal Articles

Managing patients who are receiving warfarin or a direct oral anticoagulant and need an elective surgery or procedure

James Douketis, Andrea Cervi
Journal: Blood Advances
Blood Adv (2019) 3 (12): 1925.
https://doi.org/10.1182/bloodadvances.2019000171
Published: 2019
Includes: Supplemental data
Journal Articles

Daily light-and-darkness onset regulates mouse hematopoietic stem cells

Karin Golan, Tsvee Lapidot
Journal: Blood Advances
Blood Adv (2019) 3 (4): 704.
https://doi.org/10.1182/bloodadvances.2018027722
Published: 2019
Includes: Supplemental data
Journal Articles

Extended therapy for unprovoked venous thromboembolism: when is it indicated?

Tobias Tritschler, Philip S. Wells
Journal: Blood Advances
Blood Adv (2019) 3 (3): 499.
https://doi.org/10.1182/bloodadvances.2018026518
Published: 2019
Includes: Supplemental data
Journal Articles

Geriatric assessment in acute myeloid leukemia: current and future landscape

Kah Poh Loh, Heidi D. Klepin
Journal: Blood Advances
Blood Adv (2018) 2 (18): 2418.
https://doi.org/10.1182/bloodadvances.2018016477
Published: 2018
Includes: Supplemental data
Journal Articles

Antiplatelet therapy in the management of atherothrombosis: recent clinical advances

Clinical Trials & Observations
Noel C. Chan, Jeffrey I. Weitz
Journal: Blood Advances
Blood Adv (2018) 2 (14): 1806.
https://doi.org/10.1182/bloodadvances.2018005074
Published: 2018
Includes: Supplemental data
Journal Articles

Challenges facing the benign hematology physician-scientist workforce: identifying issues of recruitment and retention

Elizabeth Soffer, William Keith Hoots
Journal: Blood Advances
Blood Adv (2018) 2 (3): 308.
https://doi.org/10.1182/bloodadvances.2017011965
Published: 2018
Includes: Supplemental data